Clinical trial
Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With…
NCT00416702 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00416702 |
|---|---|
| Title | Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function |
| Official title | An Open-Label, Single-Dose, Parallel-Group Study to Assess the Pharmacokinetics of 600 µg Indacaterol in Subjects With Impaired Hepatic Function in Comparison With Healthy Control Subjects |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hepatic Insufficiency |
| Intervention type | Drug |
| Interventions | QAB149 |
| Enrollment | 32 |
| Start date | Nov 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | Dec 28, 2006 |
| Last update posted | Jun 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: